MicroRNAs as potential therapeutic targets for pancreatic cancer

Pancreatic cancer is one of the most aggressive malignancies. The poor prognosis of pancreatic cancer patients is mainly attributed to low diagnostic rate at the early stage, highly aggressive nature coupled with the inadequate efficacy of current chemotherapeutic regimens. Novel therapeutic strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xiangyu, Wei, Dan, Liu, Xinxin, Long, Di, Tian, Xiaodong, Yang, Yinmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850815/
https://www.ncbi.nlm.nih.gov/pubmed/34839317
http://dx.doi.org/10.1097/CM9.0000000000001826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850815/
https://www.ncbi.nlm.nih.gov/pubmed/34839317
http://dx.doi.org/10.1097/CM9.0000000000001826

Ejemplares similares